16 June 2016 Written by  Harvard Gazette

First area cell transplantation center

The Harvard Stem Cell Institute (HSCI), three of Harvard’s clinical affiliates, and a biopharmaceutical company have formed an unusual collaboration to establish the Boston Autologous Islet Replacement Program (BAIRT) to accelerate a cure for diabetes.

Read the full article from Harvard Gazette (HERE)